[DPHARMA] General Meeting on 31-May-2023

Stock
[DPHARMA]: DUOPHARMA BIOTECH BERHAD
Announcement Date
26-Apr-2023
Reference No.
GMA-29032023-00014
Corporate Action ID
MY230329MEET0014
Type
General Meeting
Date & Time
31-May-2023 09:00
Depositor Date
24-May-2023
Venue
Broadcast Venue,at Meeting Rooms 403 & 404, Level 4,,Kuala Lumpur Convention Centre,,Kuala Lumpur City Centre, 50088 Kuala Lumpur,,MY
Description
The 22nd Annual General Meeting ("AGM") of Duopharma Biotech Berhad will be held on Wednesday, 31 May 2023, at 9.00 a.m. This meeting will be held virtually via remote participation through live streaming and online voting.
DBB IAR2022 - NOTICE OF THE 22ND ANNUAL GENERAL MEETING.pdf
Outcome

The Board of Directors of Duopharma Biotech Berhad("Duopharma Biotech" orthe "Company”) wishes toannouncethat the Audited Financial Statements for the financial year ended 31 December 2022and the Reports of the Directors and Auditors thereon were duly tabled and receivedat the 22nd Annual General Meeting (“AGM”) of the Company held today under Agenda 1 as set out in the Notice of the 22ndAGM dated 27April 2023.


The Boardalsowishes to announce that all the resolutionsas set out in the Notice of the 22nd AGM dated 27April 2023have beenpassed by the shareholders of Duopharma Biotech at the 22nd AGM held today.

The voting in respect of all the resolutions was carried out by way of poll and the results were validated by Scrutineer Solutions Sdn. Bhd., the independent scrutineer appointed by Duopharma Biotech.

Please refer to the attachment for the results of the poll as validated by the independent scrutineer.

This announcement is dated 31May 2023.

Voting Results

1. Ordinary Resolution 1

Description 
To re-elect Tan Sri Datin Paduka Siti Sadiah Binti Sh Bakir, who retires in accordance with Article 100 of the Company's Constitution and who, being eligible, offers herself for re-election.
Shareholder’s Action For Voting
Voted For Against
No. of Shareholders 690 123
No. of Shares 658,838,037 274,608
% of Voted Shares 99.9583 0.0417
Result Accepted

2. Ordinary Resolution 2

Description 
To re-elect Encik Leonard Ariff Bin Abdul Shatar, who retires in accordance with Article 100 of the Company's Constitution and who, being eligible, offers himself for re-election.
Shareholder’s Action For Voting
Voted For Against
No. of Shareholders 687 126
No. of Shares 658,851,672 279,648
% of Voted Shares 99.9576 0.0424
Result Accepted

3. Ordinary Resolution 3

Description 
To re-elect Puan Zaiton Binti Jamaluddin, who retires in accordance with Article 100 of the Company's Constitution and who, being eligible, offers herself for re-election.
Shareholder’s Action For Voting
Voted For Against
No. of Shareholders 689 123
No. of Shares 658,849,013 279,874
% of Voted Shares 99.9575 0.0425
Result Accepted

4. Ordinary Resolution 4

Description 
To approve the payment of Directors fees and Board Committee fees to each of the Non-Executive Directors for the period commencing 1 June 2023 until the conclusion of the next Annual General Meeting of the Company, and further, to authorise the Directors to pay the said fees among them in such proportions and manner as the Directors may determine.
Shareholder’s Action For Voting
Voted For Against
No. of Shareholders 642 166
No. of Shares 658,573,932 518,139
% of Voted Shares 99.9214 0.0786
Result Accepted

5. Ordinary Resolution 5

Description 
To approve the payment of benefits to the Non-Executive Directors up to an amount of RM768,000.00 for the period from 1 June 2023 until the conclusion of the next AGM of the Company.
Shareholder’s Action For Voting
Voted For Against
No. of Shareholders 626 180
No. of Shares 658,520,622 563,042
% of Voted Shares 99.9146 0.0854
Result Accepted

6. Ordinary Resolution 6

Description 
To re-appoint Messrs. KPMG PLT as Auditors of the Company and to authorise the Directors to fix their remuneration.
Shareholder’s Action For Voting
Voted For Against
No. of Shareholders 716 98
No. of Shares 658,884,235 245,889
% of Voted Shares 99.9627 0.0373
Result Accepted

7. Ordinary Resolution 7

Description 
To approve the Issuance of New Duopharma Biotech Shares Pursuant to the Dividend Reinvestment Plan That Provides the Shareholders of the Company with the Option to Elect to Reinvest their Dividend in New Duopharma Biotech Shares ("Dividend Reinvestment Plan").
Shareholder’s Action For Voting
Voted For Against
No. of Shareholders 692 119
No. of Shares 658,740,035 354,634
% of Voted Shares 99.9462 0.0538
Result Accepted

Remark
-
Market Buzz

2024-04-25

Meeting Notice

General Meeting on 06-Jun-2024.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment